ECR-23963-22801
2 vaccinations
2 coded responses
5 check-ins
2 free-text entries
0 call cases
- Sex
- —
- Age at first dose
- 21-25
- ZIP prefix
- 452 / OH
- Registered
- 2021-04-04
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-03
Dose 1 — Pfizer-BioNTech
-
2021-04-04
Registered in v-safe
-
2021-04-04
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-04-05
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Swelling · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-04-22
Dose 2 — Pfizer-BioNTech
- 2021-05-08
-
2021-06-08
Survey response — day 42, dose 2MedDRA: Condition aggravated, Decreased appetite, Fatigue, Haemorrhage, Headache, Hypoglycaemia, Increased tendency to bruise, Myalgia, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activitiesFree text: More frequent headaches, bouts of severe fatigue. Poor appetite & worsening [Pre.Ex.] alexithymia, sometimes leading to mild hypoglycemic states. Bruising & bleeding more easily. Unexplained muscle pain. Trouble maintaining hydration & electrolytes.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-24
Survey response — 3 months, dose 2MedDRA: Breast mass, Menstruation irregular — Feeling: Good · Be unable to do your normal daily activitiesFree text: Lump in breast tissue. Worsening of menstrual cycle; symptoms, flow, irregular length/onset of cycles. It should be noted that Ive been on testosterone for over a year and had stopped menstruating for several months prior to receiving the vaccine.MedDRA releases: 2021-09,2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-03 | Pfizer-BioNTech | |
| 2 | 2021-04-22 | Pfizer-BioNTech |
Free text
Release 8 — day 42, dose 2
Symptoms: More frequent headaches, bouts of severe fatigue. Poor appetite & worsening [Pre.Ex.] alexithymia, sometimes leading to mild hypoglycemic states. Bruising & bleeding more easily. Unexplained muscle pain. Trouble maintaining hydration & electrolytes. cut off by CDC
Release 9 — 3 months, dose 2
Symptoms: Lump in breast tissue. Worsening of menstrual cycle; symptoms, flow, irregular length/onset of cycles. It should be noted that Ive been on testosterone for over a year and had stopped menstruating for several months prior to receiving the vaccine.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Breast mass | ✓ | · | ✓ |
| SD | Condition aggravated | ✓ | ✓ | ✓ |
| SD | Decreased appetite | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Haemorrhage | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Hypoglycaemia | ✓ | ✓ | ✓ |
| SD | Increased tendency to bruise | ✓ | ✓ | ✓ |
| SD | Menstruation irregular | ✓ | · | ✓ |
| SD | Myalgia | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release